Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Lusys Laboratories, Inc.
WARNING LETTER
•Lusys Laboratories, Inc.•September 24, 2021

Lusys Laboratories, Inc. – FDA Warning Letter, Sep 24, 2021

Record Details

On February 17, 2022, the FDA issued a Warning Letter to Lusys Laboratories, Inc. following an inspection from September 13-24, 2021, at their San Diego facility. The inspection revealed that Lusys Laboratories, Inc. manufactures and distributes COVID-19 IgG/IgM Antibody Test and COVID-19 Viral Antigen Test kits in the United States.

The FDA determined these COVID-19 Test Kits are medical devices intended for the mitigation, prevention, treatment, diagnosis, or cure of COVID-19. The products were found to be adulterated under section 501(f)(1)(B) of the Act, 21 U.S.C. § 351(f)(1)(B), because they were distributed without required marketing approval, clearance, or authorization (PMA or IDE). They were also deemed misbranded under section 502(o) of the Act, 21 U.S.C. § 352(o), for failure to notify the FDA of intent to introduce the devices into commercial distribution, as required by section 510(k) of the Act, 21 U.S.C. § 360(k).

The introduction or delivery of these products into interstate commerce is prohibited under section 301(a) of the Act, 21 U.S

Company
Lusys Laboratories, Inc.
Inspection date
September 24, 2021
Product type
Devices
Office
Center for Devices and Radiological Health
Person
  • Timothy T. Stenzel (Director)
View Company Profile

ID · 5b81b74e-a5c5-4a73-98ec-969d6153265a

Violation Codes8
21 U.S.C. 331(a)21 U.S.C. 321(h)21 U.S.C. 351(f)(1)(B)21 U.S.C. 360e(a)21 U.S.C. 360j(g)21 U.S.C. 352(o)21 U.S.C. 360(k)21 U.S.C. 331(k)

Full citation text and observation details available on the Dashboard.

Other documents for Lusys Laboratories, Inc.
  • 483 - 2021-09-24September 24, 2021
  • WARNING_LETTER - 2015-05-15May 15, 2015

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Lusys Laboratories, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.